Loading...

Ray Lara

Title(s)Member, CTSI
SchoolCTSI
vCardDownload vCard
    Other Positions
    Title(s)Associate Professor, Behavioral Neuroscience

    Title(s)Associate Professor, Clinical Psychology

    Title(s)Member, Brain Research Institute

    Title(s)Member, Neuroscience GPB Home Area


    Collapse Research 
    Collapse Research Activities and Funding
    Clinical neuroscience of alcoholism: integrating neuroscience and clinical trials
    NIH/NIAAA K24AA025704Sep 15, 2018 - Aug 31, 2023
    Role: Principal Investigator
    A randomized controlled clinical trial of the neuroimmune modulator ibudilast for the treatment of alcohol use disorder
    NIH/NIAAA R01AA026190May 15, 2018 - Feb 28, 2022
    Role: Principal Investigator
    Combining varenicline and naltrexone for smoking cessation and drinking reduction
    NIH/NIDA R01DA041226Sep 1, 2015 - May 31, 2018
    Role: Principal Investigator
    Perceived alcohol reward value and risk: Neural correlates and treatment effects
    NIH/NIAAA R21AA023669Apr 1, 2015 - Mar 31, 2017
    Role: Co-Principal Investigator
    Modeling alcohol reward and reinforcement in the human laboratory
    NIH/NIAAA R21AA022752Sep 10, 2014 - Aug 31, 2016
    Role: Principal Investigator
    Optimizing naltrexone for individuals of East Asian descent
    NIH/NIAAA R01AA021744Sep 1, 2013 - Jun 30, 2016
    Role: Principal Investigator
    Development of Ibudilast as a Novel Treatment for Alcoholism
    NIH/NIAAA R21AA022214Jul 15, 2013 - Jun 30, 2015
    Role: Principal Investigator
    Pharmacogenetics of Natlrexone for Methamphetamine Use Disorder
    NIH/NIDA R21DA029831Sep 15, 2011 - Aug 31, 2013
    Role: Principal Investigator
    Neuroimaging probes of medication response in smokers
    NIH/NIDA R03DA030898Sep 20, 2010 - Aug 31, 2012
    Role: Principal Investigator
    Integrating Laboratory Neuroimaging Phenotypes
    NIH/NIAAA R03AA019569Sep 25, 2009 - Aug 31, 2011
    Role: Principal Investigator
    Genetic Correlates of Alcohol Use Disorders
    NIH/NIAAA F31AA014847Apr 1, 2004 - Mar 31, 2007
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Venegas A, Ray LA. Comparing alcohol cue-reactivity in treatment-seekers versus non-treatment-seekers with alcohol use disorder. Am J Drug Alcohol Abuse. 2019 Jul 11; 1-8. PMID: 31295037.
      View in: PubMed
    2. Grodin EN, Lim AC, MacKillop J, Karno MP, Ray LA. An Examination of Motivation to Change and Neural Alcohol Cue Reactivity Following a Brief Intervention. Front Psychiatry. 2019; 10:408. PMID: 31244697.
      View in: PubMed
    3. Ray LA, Green R, Roche DJO, Magill M, Bujarski S. Naltrexone effects on subjective responses to alcohol in the human laboratory: A systematic review and meta-analysis. Addict Biol. 2019 May 30. PMID: 31148304.
      View in: PubMed
    4. Cortland CI, Shapiro JR, Guzman IY, Ray LA. The ironic effects of stigmatizing smoking: Combining stereotype threat theory with behavioral pharmacology. Addiction. 2019 May 29. PMID: 31140666.
      View in: PubMed
    5. Lim AC, Ghahremani DG, Grodin EN, Green R, Bujarski S, Hartwell EE, Courtney KE, Hutchison K, Miotto K, Ray LA. Neuroimaging findings from an experimental pharmacology trial of naltrexone in heavy drinkers of East Asian descent. Drug Alcohol Depend. 2019 Jul 01; 200:181-190. PMID: 31160146.
      View in: PubMed
    6. Green R, Grodin E, Lim AC, Venegas A, Bujarski S, Krull J, Ray LA. The Interplay Between Subjective Response to Alcohol, Craving, and Alcohol Self-Administration in the Human Laboratory. Alcohol Clin Exp Res. 2019 May; 43(5):907-915. PMID: 30860603.
      View in: PubMed
    7. Grodin EN, Courtney KE, Ray LA. Drug-Induced Craving for Methamphetamine Is Associated With Neural Methamphetamine Cue Reactivity. J Stud Alcohol Drugs. 2019 Mar; 80(2):245-251. PMID: 31014470.
      View in: PubMed
    8. Grodin EN, Ray LA, MacKillop J, Lim AC, Karno MP. Elucidating the Effect of a Brief Drinking Intervention Using Neuroimaging: A Preliminary Study. Alcohol Clin Exp Res. 2019 Feb; 43(2):367-377. PMID: 30556913.
      View in: PubMed
    9. Green R, Bujarski S, Lim AC, Venegas A, Ray LA. Naltrexone and alcohol effects on craving for cigarettes in heavy drinking smokers. Exp Clin Psychopharmacol. 2019 Jan 10. PMID: 30628813.
      View in: PubMed
    10. Falk DE, Ryan ML, Fertig JB, Devine EG, Cruz R, Brown ES, Burns H, Salloum IM, Newport DJ, Mendelson J, Galloway G, Kampman K, Brooks C, Green AI, Brunette MF, Rosenthal RN, Dunn KE, Strain EC, Ray L, Shoptaw S, Ait-Daoud Tiouririne N, Gunderson EW, Ransom J, Scott C, Leggio L, Caras S, Mason BJ, Litten RZ. Gabapentin Enacarbil Extended-Release for Alcohol Use Disorder: A Randomized, Double-Blind, Placebo-Controlled, Multisite Trial Assessing Efficacy and Safety. Alcohol Clin Exp Res. 2019 Jan; 43(1):158-169. PMID: 30403402.
      View in: PubMed
    11. Ray LA, Lim AC, Shoptaw S. What defines a clinically meaningful outcome in the treatment of substance use disorders: 'Getting your life back'. Addiction. 2019 Jan; 114(1):18-20. PMID: 30426617.
      View in: PubMed
    12. Lim AC, Roche DJO, Ray LA. Distress Tolerance and Craving for Cigarettes Among Heavy Drinking Smokers. J Stud Alcohol Drugs. 2018 Nov; 79(6):918-928. PMID: 30573023.
      View in: PubMed
    13. Ray LA, Bujarski S, Grodin E, Hartwell E, Green R, Venegas A, Lim AC, Gillis A, Miotto K. State-of-the-art behavioral and pharmacological treatments for alcohol use disorder. Am J Drug Alcohol Abuse. 2019; 45(2):124-140. PMID: 30373394.
      View in: PubMed
    14. Cummings JR, Tomiyama AJ, Ray LA. Does the Neuroimmune Modulator Ibudilast Alter Food Craving? Results in a Sample With Alcohol Use Disorder. J Addict Med. 2018 Sep/Oct; 12(5):410-417. PMID: 29794557.
      View in: PubMed
    15. Lim AC, Courtney KE, Moallem NR, Allen VC, Leventhal AM, Ray LA. A Brief Smoking Cessation Intervention for Heavy Drinking Smokers: Treatment Feasibility and Acceptability. Front Psychiatry. 2018; 9:362. PMID: 30147661.
      View in: PubMed
    16. Bello MS, McBeth JF, Ditre JW, Kirkpatrick MG, Ray LA, Dunn KE, Leventhal AM. Pain as a predictor and consequence of tobacco abstinence effects amongst African American smokers. J Abnorm Psychol. 2018 Oct; 127(7):683-694. PMID: 30070540.
      View in: PubMed
    17. Ray LA, Bujarski S, Roche DJO, Magill M. Overcoming the "Valley of Death" in Medications Development for Alcohol Use Disorder. Alcohol Clin Exp Res. 2018 Sep; 42(9):1612-1622. PMID: 29969156.
      View in: PubMed
    18. Allen VC, Ray LA, Myers HF. Examining the Sexual Health Consequences of Alcohol Consumption Among Black Gay and Bisexual Men. Alcohol Clin Exp Res. 2018 Jun 20. PMID: 29924387.
      View in: PubMed
    19. Bujarski S, Jentsch JD, Roche DJO, Ramchandani VA, Miotto K, Ray LA. Differences in the subjective and motivational properties of alcohol across alcohol use severity: application of a novel translational human laboratory paradigm. Neuropsychopharmacology. 2018 08; 43(9):1891-1899. PMID: 29802367.
      View in: PubMed
    20. Hartwell EE, Ray LA. Craving as a DSM-5 Symptom of Alcohol Use Disorder in Non-Treatment Seekers. Alcohol Alcohol. 2018 May 01; 53(3):235-240. PMID: 29145640.
      View in: PubMed
    21. Green R, Ray LA. Effects of varenicline on subjective craving and relative reinforcing value of cigarettes. Drug Alcohol Depend. 2018 Jul 01; 188:53-59. PMID: 29751347.
      View in: PubMed
    22. Moallem NR, Courtney KE, Ray LA. The relationship between impulsivity and methamphetamine use severity in a community sample. Drug Alcohol Depend. 2018 06 01; 187:1-7. PMID: 29626740.
      View in: PubMed
    23. Hartwell EE, Ray LA. Relationship between tonic and phasic craving for alcohol. Addict Behav Rep. 2018 Jun; 7:71-74. PMID: 29892699.
      View in: PubMed
    24. Ray LA, Green R, Roche DJO, Bujarski S, Hartwell EE, Lim AC, Rohrbaugh T, Ghahremani D, Hutchison K, Miotto K. Pharmacogenetic Effects of Naltrexone in Individuals of East Asian Descent: Human Laboratory Findings from a Randomized Trial. Alcohol Clin Exp Res. 2018 Mar; 42(3):613-623. PMID: 29265379.
      View in: PubMed
    25. Cservenka A, Courtney KE, Ghahremani DG, Hutchison KE, Ray LA. Development, Initial Testing and Challenges of an Ecologically Valid Reward Prediction Error FMRI Task for Alcoholism. Alcohol Alcohol. 2017 Sep 01; 52(5):617-624. PMID: 28633363.
      View in: PubMed
    26. Lim AC, Cservenka A, Ray LA. Effects of Alcohol Dependence Severity on Neural Correlates of Delay Discounting. Alcohol Alcohol. 2017 Jul 01; 52(4):506-515. PMID: 28340213.
      View in: PubMed
    27. Chokron Garneau H, Venegas A, Rawson R, Ray LA, Glasner S. Barriers to initiation of extended release naltrexone among HIV-infected adults with alcohol use disorders. J Subst Abuse Treat. 2018 Feb; 85:34-37. PMID: 28527854.
      View in: PubMed
    28. Ray LA, Bujarski S, Yardley MM, Roche DJO, Hartwell EE. Differences between treatment-seeking and non-treatment-seeking participants in medication studies for alcoholism: do they matter? Am J Drug Alcohol Abuse. 2017 11; 43(6):703-710. PMID: 28426264.
      View in: PubMed
    29. Roche DJO, Worley MJ, Courtney KE, Bujarski S, London ED, Shoptaw S, Ray LA. Naltrexone moderates the relationship between cue-induced craving and subjective response to methamphetamine in individuals with methamphetamine use disorder. Psychopharmacology (Berl). 2017 Jul; 234(13):1997-2007. PMID: 28357460.
      View in: PubMed
    30. Westman JG, Bujarski S, Ray LA. Impulsivity Moderates Subjective Responses to Alcohol in Alcohol-Dependent Individuals. Alcohol Alcohol. 2017 Mar 09; 52(2):249-255. PMID: 28003245.
      View in: PubMed
    31. Ray LA, Bujarski S, Shoptaw S, Roche DJ, Heinzerling K, Miotto K. Development of the Neuroimmune Modulator Ibudilast for the Treatment of Alcoholism: A Randomized, Placebo-Controlled, Human Laboratory Trial. Neuropsychopharmacology. 2017 Aug; 42(9):1776-1788. PMID: 28091532.
      View in: PubMed
    32. Bullock K, Cservenka A, Ray LA. Severity of alcohol dependence is negatively related to hypothalamic and prefrontal cortical gray matter density in heavy drinking smokers. Am J Drug Alcohol Abuse. 2017 05; 43(3):281-290. PMID: 27996310.
      View in: PubMed
    33. Cservenka A, Yardley MM, Ray LA. Review: Pharmacogenetics of alcoholism treatment: Implications of ethnic diversity. Am J Addict. 2017 Aug; 26(5):516-525. PMID: 28134463.
      View in: PubMed
    34. Hartwell EE, Moallem NR, Courtney KE, Glasner-Edwards S, Ray LA. Sex Differences in the Association Between Internalizing Symptoms and Craving in Methamphetamine Users. J Addict Med. 2016 Nov/Dec; 10(6):395-401. PMID: 27504928.
      View in: PubMed
    35. Bello MS, Pang RD, Chasson GS, Ray LA, Leventhal AM. Obsessive-compulsive symptoms and negative affect during tobacco withdrawal in a non-clinical sample of African American smokers. J Anxiety Disord. 2017 May; 48:78-86. PMID: 27769664.
      View in: PubMed
    36. Cservenka A, Ray LA. Self-reported attentional and motor impulsivity are related to age at first methamphetamine use. Addict Behav. 2017 02; 65:7-12. PMID: 27701027.
      View in: PubMed
    37. Chung T, Noronha A, Carroll KM, Potenza MN, Hutchison K, Calhoun VD, Gabrieli JD, Morgenstern J, Nixon SJ, Wexler BE, Brewer J, Ray L, Filbey F, Strauman TJ, Kober H, Feldstein Ewing SW. Brain mechanisms of Change in Addictions Treatment: Models, Methods, and Emerging Findings. Curr Addict Rep. 2016 Sep; 3(3):332-342. PMID: 27990326.
      View in: PubMed
    38. Courtney KE, Ghahremani DG, Ray LA. The Effects of Pharmacological Opioid Blockade on Neural Measures of Drug Cue-Reactivity in Humans. Neuropsychopharmacology. 2016 11; 41(12):2872-2881. PMID: 27312405.
      View in: PubMed
    39. Bujarski S, Ray LA. Experimental psychopathology paradigms for alcohol use disorders: Applications for translational research. Behav Res Ther. 2016 11; 86:11-22. PMID: 27266992.
      View in: PubMed
    40. Green R, Bujarski S, Roche DJ, Ray LA. Relationship between negative affect and smoking topography in heavy drinking smokers. Addict Behav. 2016 10; 61:53-7. PMID: 27240211.
      View in: PubMed
    41. Roche DJ, Yardley MM, Lunny KF, Louie SG, Davies DL, Miotto K, Ray LA. A Pilot Study of the Safety and Initial Efficacy of Ivermectin for the Treatment of Alcohol Use Disorder. Alcohol Clin Exp Res. 2016 06; 40(6):1312-20. PMID: 27087145.
      View in: PubMed
    42. Roche DJ, Ray LA, Yardley MM, King AC. Current insights into the mechanisms and development of treatments for heavy drinking cigarette smokers. Curr Addict Rep. 2016 Mar; 3(1):125-137. PMID: 27162709.
      View in: PubMed
    43. Yardley MM, Ray LA. Medications development for the treatment of alcohol use disorder: insights into the predictive value of animal and human laboratory models. Addict Biol. 2017 May; 22(3):581-615. PMID: 26833803.
      View in: PubMed
    44. Inagaki TK, Ray LA, Irwin MR, Way BM, Eisenberger NI. Opioids and social bonding: naltrexone reduces feelings of social connection. Soc Cogn Affect Neurosci. 2016 05; 11(5):728-35. PMID: 26796966; PMCID: PMC4847702 [Available on 05/01/17].
    45. Ray LA, Bujarski S, Roche DJ. Subjective Response to Alcohol as a Research Domain Criterion. Alcohol Clin Exp Res. 2016 Jan; 40(1):6-17. PMID: 26727518.
      View in: PubMed
    46. Squeglia LM, Brammer WA, Ray LA, Lee SS. Attention Deficit/Hyperactivity Disorder (ADHD) Symptoms Predict Alcohol Expectancy Development. J Child Adolesc Subst Abuse. 2016 Mar 01; 25(2):159-179. PMID: 27110089.
      View in: PubMed
    47. Moore AA, Karno MP, Ray L, Ramirez K, Barenstein V, Portillo MJ, Rizo P, Borok J, Liao DH, Barron J, del Pino HE, Valenzuela A, Barry KL. Development and Preliminary Testing of a Promotora-Delivered, Spanish Language, Counseling Intervention for Heavy Drinking among Male, Latino Day Laborers. J Subst Abuse Treat. 2016 Mar; 62:96-101. PMID: 26738641.
      View in: PubMed
    48. Cummings JR, Ray LA, Tomiyama AJ. Food-alcohol competition: As young females eat more food, do they drink less alcohol? J Health Psychol. 2017 04; 22(5):674-683. PMID: 26542418.
      View in: PubMed
    49. Courtney KE, Ray LA. Clinical neuroscience of amphetamine-type stimulants: From basic science to treatment development. Prog Brain Res. 2016; 223:295-310. PMID: 26806782.
      View in: PubMed
    50. Courtney KE, Schacht JP, Hutchison K, Roche DJ, Ray LA. Neural substrates of cue reactivity: association with treatment outcomes and relapse. Addict Biol. 2016 Jan; 21(1):3-22. PMID: 26435524; PMCID: PMC4986996.
    51. Bujarski S, Lau AS, Lee SS, Ray LA. Genetic and Environmental Predictors of Alcohol Use in Asian American Young Adults. J Stud Alcohol Drugs. 2015 Sep; 76(5):690-9. PMID: 26402349.
      View in: PubMed
    52. Allen VC, Myers HF, Ray L. The Association Between Alcohol Consumption and Condom Use: Considering Correlates of HIV Risk Among Black Men Who Have Sex with Men. AIDS Behav. 2015 Sep; 19(9):1689-700. PMID: 25935215.
      View in: PubMed
    53. Bujarski S, Hutchison KE, Prause N, Ray LA. Functional significance of subjective response to alcohol across levels of alcohol exposure. Addict Biol. 2017 Jan; 22(1):235-245. PMID: 26256114.
      View in: PubMed
    54. Courtney KE, Ghahremani DG, Ray LA. The effect of alcohol priming on neural markers of alcohol cue-reactivity. Am J Drug Alcohol Abuse. 2015; 41(4):300-8. PMID: 26125586; PMCID: PMC4651007.
    55. Bidwell LC, Knopik VS, Audrain-McGovern J, Glynn TR, Spillane NS, Ray LA, Riggs NR, Guillot CR, Pang RD, Leventhal AM. Novelty Seeking as a Phenotypic Marker of Adolescent Substance Use. Subst Abuse. 2015; 9(Suppl 1):1-10. PMID: 26106262.
      View in: PubMed
    56. Hartwell EE, Bujarski S, Glasner-Edwards S, Ray LA. The Association of Alcohol Severity and Sleep Quality in Problem Drinkers. Alcohol Alcohol. 2015 Sep; 50(5):536-41. PMID: 26018218.
      View in: PubMed
    57. Bujarski S, Hutchison KE, Roche DJ, Ray LA. Factor Structure of Subjective Responses to Alcohol in Light and Heavy Drinkers. Alcohol Clin Exp Res. 2015 Jul; 39(7):1193-202. PMID: 26010049.
      View in: PubMed
    58. Roche DJ, Ray LA. Subjective response as a consideration in the pharmacogenetics of alcoholism treatment. Pharmacogenomics. 2015; 16(7):721-36. PMID: 25950242.
      View in: PubMed
    59. Roche DJ, Bujarski S, Hartwell E, Green R, Ray LA. Combined varenicline and naltrexone treatment reduces smoking topography intensity in heavy-drinking smokers. Pharmacol Biochem Behav. 2015 Jul; 134:92-8. PMID: 25933795.
      View in: PubMed
    60. Ray LA, Bujarski S. Mechanisms of topiramate effects: refining medications development for alcoholism. Addict Biol. 2016 Jan; 21(1):183-184. PMID: 25876675.
      View in: PubMed
    61. Sheets ES, Bujarski S, Leventhal AM, Ray LA. Emotion differentiation and intensity during acute tobacco abstinence: A comparison of heavy and light smokers. Addict Behav. 2015 Aug; 47:70-3. PMID: 25885662.
      View in: PubMed
    62. Bujarski S, Roche DJ, Sheets ES, Krull JL, Guzman I, Ray LA. Modeling naturalistic craving, withdrawal, and affect during early nicotine abstinence: A pilot ecological momentary assessment study. Exp Clin Psychopharmacol. 2015 Apr; 23(2):81-9. PMID: 25844632.
      View in: PubMed
    63. Ray LA. A matter of outlook. Alcohol Clin Exp Res. 2015 Apr; 39(4):590. PMID: 25833019.
      View in: PubMed
    64. Ray LA, Bujarski S, Courtney KE, Moallem NR, Lunny K, Roche D, Leventhal AM, Shoptaw S, Heinzerling K, London ED, Miotto K. The Effects of Naltrexone on Subjective Response to Methamphetamine in a Clinical Sample: a Double-Blind, Placebo-Controlled Laboratory Study. Neuropsychopharmacology. 2015 Sep; 40(10):2347-56. PMID: 25801501; PMCID: PMC4538349.
    65. Yardley MM, Mirbaba MM, Ray LA. Pharmacological Options for Smoking Cessation in Heavy-Drinking Smokers. CNS Drugs. 2015; 29(10):833-45. PMID: 26507831.
      View in: PubMed
    66. Owens MM, Ray LA, MacKillop J. Behavioral economic analysis of stress effects on acute motivation for alcohol. J Exp Anal Behav. 2015 Jan; 103(1):77-86. PMID: 25413719.
      View in: PubMed
    67. Courtney KE, Ray LA. Methamphetamine: an update on epidemiology, pharmacology, clinical phenomenology, and treatment literature. Drug Alcohol Depend. 2014 Oct 01; 143:11-21. PMID: 25176528; PMCID: PMC4164186.
    68. Bacio GA, Guzman IY, Shapiro JR, Ray LA. Differences in quit attempts between non-Hispanic Black and White daily smokers: the role of smoking motives. Addict Behav. 2014 Dec; 39(12):1769-72. PMID: 25123344.
      View in: PubMed
    69. Bujarski S, Ray LA. Negative affect is associated with alcohol, but not cigarette use in heavy drinking smokers. Addict Behav. 2014 Dec; 39(12):1723-9. PMID: 25117849.
      View in: PubMed
    70. Sujan AC, Humphreys KL, Ray LA, Lee SS. Differential association of child abuse with self-reported versus laboratory-based impulsivity and risk-taking in young adulthood. Child Maltreat. 2014 Aug-Nov; 19(3-4):145-55. PMID: 25034226.
      View in: PubMed
    71. Ray LA, Courtney KE, Ghahremani DG, Miotto K, Brody A, London ED. Varenicline, naltrexone, and their combination for heavy-drinking smokers: preliminary neuroimaging findings. Am J Drug Alcohol Abuse. 2015 Jan; 41(1):35-44. PMID: 24949564; PMCID: PMC4365972.
    72. Bujarski S, Roche DJ, Lunny K, Moallem NR, Courtney KE, Allen V, Hartwell E, Leventhal A, Rohrbaugh T, Ray LA. The relationship between methamphetamine and alcohol use in a community sample of methamphetamine users. Drug Alcohol Depend. 2014 Sep 01; 142:127-32. PMID: 24975477; PMCID: PMC4157644.
    73. Bacio G, Moore A, Karno M, Ray L. Determinants of problem drinking and depression among Latino Day laborers. Subst Use Misuse. 2014 Jun; 49(8):1039-48. PMID: 24779503.
      View in: PubMed
    74. Ashenhurst JR, Bujarski S, Jentsch JD, Ray LA. Modeling behavioral reactivity to losses and rewards on the Balloon Analogue Risk Task (BART): moderation by alcohol problem severity. Exp Clin Psychopharmacol. 2014 Aug; 22(4):298-306. PMID: 24840639.
      View in: PubMed
    75. Courtney KE, Ghahremani DG, London ED, Ray LA. The association between cue-reactivity in the precuneus and level of dependence on nicotine and alcohol. Drug Alcohol Depend. 2014 Aug 01; 141:21-6. PMID: 24880692; PMCID: PMC4166553.
    76. DeMartini KS, Devine EG, DiClemente CC, Martin DJ, Ray LA, O'Malley SS. Predictors of pretreatment commitment to abstinence: results from the COMBINE study. J Stud Alcohol Drugs. 2014 May; 75(3):438-46. PMID: 24766756.
      View in: PubMed
    77. Bujarski S, Ray LA. Subjective response to alcohol and associated craving in heavy drinkers vs. alcohol dependents: an examination of Koob's allostatic model in humans. Drug Alcohol Depend. 2014 Jul 01; 140:161-7. PMID: 24837580.
      View in: PubMed
    78. Ray LA, Courtney KE, Ghahremani DG, Miotto K, Brody A, London ED. Varenicline, low dose naltrexone, and their combination for heavy-drinking smokers: human laboratory findings. Psychopharmacology (Berl). 2014 Oct; 231(19):3843-53. PMID: 24733235; PMCID: PMC4161630.
    79. MacKillop J, Amlung MT, Acker J, Gray JC, Brown CL, Murphy JG, Ray LA, Sweet LH. The neuroeconomics of alcohol demand: an initial investigation of the neural correlates of alcohol cost-benefit decision making in heavy drinking men. Neuropsychopharmacology. 2014 Jul; 39(8):1988-95. PMID: 24584331.
      View in: PubMed
    80. Roche DJ, Bujarski S, Moallem NR, Guzman I, Shapiro JR, Ray LA. Predictors of smoking lapse in a human laboratory paradigm. Psychopharmacology (Berl). 2014 Jul; 231(14):2889-97. PMID: 24500677.
      View in: PubMed
    81. Miranda R, Monti PM, Ray L, Treloar HR, Reynolds EK, Ramirez J, Chun T, Gwaltney CJ, Justus A, Tidey J, Blanchard A, Magill M. Characterizing subjective responses to alcohol among adolescent problem drinkers. J Abnorm Psychol. 2014 Feb; 123(1):117-29. PMID: 24661164.
      View in: PubMed
    82. Ray LA, Bujarski S, Squeglia LM, Ashenhurst JR, Anton RF. Interactive effects of OPRM1 and DAT1 genetic variation on subjective responses to alcohol. Alcohol Alcohol. 2014 May-Jun; 49(3):261-70. PMID: 24421289.
      View in: PubMed
    83. Courtney KE, Ray LA. Subjective responses to alcohol in the lab predict neural responses to alcohol cues. J Stud Alcohol Drugs. 2014 Jan; 75(1):124-35. PMID: 24411804; PMCID: PMC3893626.
    84. Ray LA, Roche DJ, Heinzerling K, Shoptaw S. Opportunities for the development of neuroimmune therapies in addiction. Int Rev Neurobiol. 2014; 118:381-401. PMID: 25175870.
      View in: PubMed
    85. Lin JC, Karno MP, Grella CE, Ray LA, Liao DH, Moore AA. Psychiatric correlates of alcohol and tobacco use disorders in U.S. adults aged 65 years and older: results from the 2001-2002 National Epidemiologic Survey of Alcohol and Related Conditions. Am J Geriatr Psychiatry. 2014 Nov; 22(11):1356-63. PMID: 24021218.
      View in: PubMed
    86. Courtney KE, Ashenhurst J, Bacio G, Moallem N, Bujarski S, Hartwell E, Ray LA. Craving and subjective responses to alcohol administration: validation of the desires for alcohol questionnaire in the human laboratory. J Stud Alcohol Drugs. 2013 Sep; 74(5):797-802. PMID: 23948540; PMCID: PMC3749322.
    87. Moallem NR, Courtney KE, Bacio GA, Ray LA. Modeling alcohol use disorder severity: an integrative structural equation modeling approach. Front Psychiatry. 2013; 4:75. PMID: 23908635.
      View in: PubMed
    88. Ray LA, Courtney KE, Hutchison KE, Mackillop J, Galvan A, Ghahremani DG. Initial evidence that OPRM1 genotype moderates ventral and dorsal striatum functional connectivity during alcohol cues. Alcohol Clin Exp Res. 2014 Jan; 38(1):78-89. PMID: 23876228; PMCID: PMC3808494.
    89. Hartwell EE, Ray LA. Sex moderates stress reactivity in heavy drinkers. Addict Behav. 2013 Nov; 38(11):2643-6. PMID: 23899426.
      View in: PubMed
    90. Bacio GA, Lunny KF, Webb JN, Ray LA. Alcohol use following an alcohol challenge and a brief intervention among alcohol-dependent individuals. Am J Addict. 2014 Jan-Feb; 23(1):96-101. PMID: 24313247.
      View in: PubMed
    91. Miranda R, Ray L, Blanchard A, Reynolds EK, Monti PM, Chun T, Justus A, Swift RM, Tidey J, Gwaltney CJ, Ramirez J. Effects of naltrexone on adolescent alcohol cue reactivity and sensitivity: an initial randomized trial. Addict Biol. 2014 Sep; 19(5):941-54. PMID: 23489253.
      View in: PubMed
    92. Ray LA, Lunny K, Bujarski S, Moallem N, Krull JL, Miotto K. The effects of varenicline on stress-induced and cue-induced craving for cigarettes. Drug Alcohol Depend. 2013 Jul 01; 131(1-2):136-42. PMID: 23298651.
      View in: PubMed
    93. Ray LA, Bujarski S, MacKillop J, Courtney KE, Monti PM, Miotto K. Subjective response to alcohol among alcohol-dependent individuals: effects of the µ-opioid receptor (OPRM1) gene and alcoholism severity. Alcohol Clin Exp Res. 2013 Jan; 37 Suppl 1:E116-24. PMID: 23240711; PMCID: PMC3548029.
    94. Courtney KE, Ghahremani DG, Ray LA. Fronto-striatal functional connectivity during response inhibition in alcohol dependence. Addict Biol. 2013 May; 18(3):593-604. PMID: 23240858; PMCID: PMC3683582.
    95. Bujarski S, O'Malley SS, Lunny K, Ray LA. The effects of drinking goal on treatment outcome for alcoholism. J Consult Clin Psychol. 2013 Feb; 81(1):13-22. PMID: 23231573.
      View in: PubMed
    96. Bholat MA, Ray L, Brensilver M, Ling K, Shoptaw S. Integration of behavioral medicine in primary care. Prim Care. 2012 Dec; 39(4):605-14. PMID: 23148953.
      View in: PubMed
    97. Miranda R, Reynolds E, Ray L, Justus A, Knopik VS, McGeary J, Meyerson LA. Preliminary evidence for a gene-environment interaction in predicting alcohol use disorders in adolescents. Alcohol Clin Exp Res. 2013 Feb; 37(2):325-31. PMID: 23136901.
      View in: PubMed
    98. Ashenhurst JR, Bujarski S, Ray LA. Delta and kappa opioid receptor polymorphisms influence the effects of naltrexone on subjective responses to alcohol. Pharmacol Biochem Behav. 2012 Dec; 103(2):253-9. PMID: 22954510.
      View in: PubMed
    99. MacKillop J, Amlung MT, Wier LM, David SP, Ray LA, Bickel WK, Sweet LH. The neuroeconomics of nicotine dependence: a preliminary functional magnetic resonance imaging study of delay discounting of monetary and cigarette rewards in smokers. Psychiatry Res. 2012 Apr 30; 202(1):20-9. PMID: 22633679.
      View in: PubMed
    100. Bujarski S, MacKillop J, Ray LA. Understanding naltrexone mechanism of action and pharmacogenetics in Asian Americans via behavioral economics: a preliminary study. Exp Clin Psychopharmacol. 2012 Jun; 20(3):181-90. PMID: 22429255.
      View in: PubMed
    101. Moallem NR, Ray LA. Dimensions of impulsivity among heavy drinkers, smokers, and heavy drinking smokers: singular and combined effects. Addict Behav. 2012 Jul; 37(7):871-4. PMID: 22445419.
      View in: PubMed
    102. Tartter MA, Ray LA. A prospective study of stress and alcohol craving in heavy drinkers. Pharmacol Biochem Behav. 2012 Jun; 101(4):625-31. PMID: 22446386.
      View in: PubMed
    103. Plebani JG, Ray LA, Morean ME, Corbin WR, MacKillop J, Amlung M, King AC. Human laboratory paradigms in alcohol research. Alcohol Clin Exp Res. 2012 Jun; 36(6):972-83. PMID: 22309888.
      View in: PubMed
    104. Heinzerling KG, McCracken JT, Swanson AN, Ray LA, Shoptaw SJ. COMT Val158Met, BDNF Val66Met, and OPRM1 Asn40Asp and methamphetamine dependence treatment response: preliminary investigation. J Clin Psychopharmacol. 2012 Feb; 32(1):135-7. PMID: 22217949; PMCID: PMC3597465.
    105. Ray LA, Courtney KE, Bujarski S, Squeglia LM. Pharmacogenetics of alcoholism: a clinical neuroscience perspective. Pharmacogenomics. 2012 Jan; 13(2):129-32. PMID: 22256863; PMCID: PMC3683583.
    106. Leventhal AM, Ray LA, Rhee SH, Unger JB. Genetic and environmental influences on the association between depressive symptom dimensions and smoking initiation among Chinese adolescent twins. Nicotine Tob Res. 2012 May; 14(5):559-68. PMID: 22180578.
      View in: PubMed
    107. Courtney KE, Arellano R, Barkley-Levenson E, Gálvan A, Poldrack RA, Mackillop J, Jentsch JD, Ray LA. The relationship between measures of impulsivity and alcohol misuse: an integrative structural equation modeling approach. Alcohol Clin Exp Res. 2012 Jun; 36(6):923-31. PMID: 22091877.
      View in: PubMed
    108. Moallem N, Ray LA. Quetiapine improves response inhibition in alcohol dependent patients: a placebo-controlled pilot study. Pharmacol Biochem Behav. 2012 Jan; 100(3):490-3. PMID: 22037407.
      View in: PubMed
    109. Ashenhurst JR, Jentsch JD, Ray LA. Risk-taking and alcohol use disorders symptomatology in a sample of problem drinkers. Exp Clin Psychopharmacol. 2011 Oct; 19(5):361-70. PMID: 21707191; PMCID: PMC4166528.
    110. Hutchison KE, Ray LA. New approaches to identifying rare genetic variants associated with nicotine dependence. Biol Psychiatry. 2011 Sep 15; 70(6):500-1. PMID: 21864734.
      View in: PubMed
    111. Ray LA, Bujarski S, Chin PF, Miotto K. Pharmacogenetics of naltrexone in asian americans: a randomized placebo-controlled laboratory study. Neuropsychopharmacology. 2012 Jan; 37(2):445-55. PMID: 21900886.
      View in: PubMed
    112. Ray LA, Barr CS, Blendy JA, Oslin D, Goldman D, Anton RF. The role of the Asn40Asp polymorphism of the mu opioid receptor gene (OPRM1) on alcoholism etiology and treatment: a critical review. Alcohol Clin Exp Res. 2012 Mar; 36(3):385-94. PMID: 21895723.
      View in: PubMed
    113. Tartter MA, Ray LA. The Serotonin Transporter Polymorphism (5-HTTLPR) and Alcohol Problems in Heavy Drinkers: Moderation by Depressive Symptoms. Front Psychiatry. 2011; 2:49. PMID: 21852976.
      View in: PubMed
    114. Ray LA, Chin PF, Heydari A, Miotto K. A human laboratory study of the effects of quetiapine on subjective intoxication and alcohol craving. Psychopharmacology (Berl). 2011 Oct; 217(3):341-51. PMID: 21487653.
      View in: PubMed
    115. MacKillop J, Amlung MT, Few LR, Ray LA, Sweet LH, Munafò MR. Delayed reward discounting and addictive behavior: a meta-analysis. Psychopharmacology (Berl). 2011 Aug; 216(3):305-21. PMID: 21373791.
      View in: PubMed
    116. Ferriter C, Ray LA. Binge eating and binge drinking: an integrative review. Eat Behav. 2011 Apr; 12(2):99-107. PMID: 21385638.
      View in: PubMed
    117. Ray LA, Hart E, Chelminski I, Young D, Zimmerman M. Clinical correlates of desire for treatment for current alcohol dependence among patients with a primary psychiatric disorder. Am J Drug Alcohol Abuse. 2011 Mar; 37(2):105-10. PMID: 21219256.
      View in: PubMed
    118. Leventhal AM, Brightman M, Ameringer KJ, Greenberg J, Mickens L, Ray LA, Sun P, Sussman S. Anhedonia associated with stimulant use and dependence in a population-based sample of American adults. Exp Clin Psychopharmacol. 2010 Dec; 18(6):562-9. PMID: 21186931.
      View in: PubMed
    119. Ray LA, Hart EJ, Chin PF. Self-Rating of the Effects of Alcohol (SRE): Predictive utility and reliability across interview and self-report administrations. Addict Behav. 2011 Mar; 36(3):241-3. PMID: 21095629.
      View in: PubMed
    120. Ray LA, Krull JL, Leggio L. The Effects of Naltrexone Among Alcohol Non-Abstainers: Results from the COMBINE Study. Front Psychiatry. 2010; 1:26. PMID: 21423437.
      View in: PubMed
    121. Ray LA. Stress-induced and cue-induced craving for alcohol in heavy drinkers: Preliminary evidence of genetic moderation by the OPRM1 and CRH-BP genes. Alcohol Clin Exp Res. 2011 Jan; 35(1):166-74. PMID: 21039637.
      View in: PubMed
    122. Ray LA, Heydari A, Zorick T. Quetiapine for the treatment of alcoholism: scientific rationale and review of the literature. Drug Alcohol Rev. 2010 Sep; 29(5):568-75. PMID: 20887583.
      View in: PubMed
    123. Ray LA, Mackillop J, Monti PM. Subjective responses to alcohol consumption as endophenotypes: advancing behavioral genetics in etiological and treatment models of alcoholism. Subst Use Misuse. 2010 Sep; 45(11):1742-65. PMID: 20590398.
      View in: PubMed
    124. MacKillop J, O'Hagen S, Lisman SA, Murphy JG, Ray LA, Tidey JW, McGeary JE, Monti PM. Behavioral economic analysis of cue-elicited craving for alcohol. Addiction. 2010 Sep; 105(9):1599-607. PMID: 20626376.
      View in: PubMed
    125. Ray LA, Hutchison KE, Ashenhurst JR, Morrow AL. Naltrexone selectively elevates GABAergic neuroactive steroid levels in heavy drinkers with the Asp40 allele of the OPRM1 gene: a pilot investigation. Alcohol Clin Exp Res. 2010 Aug; 34(8):1479-87. PMID: 20528823.
      View in: PubMed
    126. Ray LA, Chin PF, Miotto K. Naltrexone for the treatment of alcoholism: clinical findings, mechanisms of action, and pharmacogenetics. CNS Neurol Disord Drug Targets. 2010 Mar; 9(1):13-22. PMID: 20201811.
      View in: PubMed
    127. MacKillop J, Miranda R, Monti PM, Ray LA, Murphy JG, Rohsenow DJ, McGeary JE, Swift RM, Tidey JW, Gwaltney CJ. Alcohol demand, delayed reward discounting, and craving in relation to drinking and alcohol use disorders. J Abnorm Psychol. 2010 Feb; 119(1):106-14. PMID: 20141247.
      View in: PubMed
    128. Ray LA, Miranda R, Tidey JW, McGeary JE, MacKillop J, Gwaltney CJ, Rohsenow DJ, Swift RM, Monti PM. Polymorphisms of the mu-opioid receptor and dopamine D4 receptor genes and subjective responses to alcohol in the natural environment. J Abnorm Psychol. 2010 Feb; 119(1):115-25. PMID: 20141248.
      View in: PubMed
    129. Ray LA, Hutchison KE, Tartter M. Application of human laboratory models to pharmacotherapy development for alcohol dependence. Curr Pharm Des. 2010; 16(19):2149-58. PMID: 20482505.
      View in: PubMed
    130. Ray LA, Capone C, Sheets E, Young D, Chelminski I, Zimmerman M. Posttraumatic stress disorder with and without alcohol use disorders: diagnostic and clinical correlates in a psychiatric sample. Psychiatry Res. 2009 Dec 30; 170(2-3):278-81. PMID: 19900714.
      View in: PubMed
    131. Witkiewitz K, Holmes A, Ray LA, Murphy JG, Richardson HN, Chen YC, McDevitt-Murphy ME, Cruz MT, Roberto M. Young Investigator Award symposium. Alcohol. 2009 Nov; 43(7):499-508. PMID: 19913193.
      View in: PubMed
    132. Miranda R, Ray L, Justus A, Meyerson LA, Knopik VS, McGeary J, Monti PM. Initial evidence of an association between OPRM1 and adolescent alcohol misuse. Alcohol Clin Exp Res. 2010 Jan; 34(1):112-22. PMID: 19860800.
      View in: PubMed
    133. Ray LA, MacKillop J, Leventhal A, Hutchison KE. Catching the alcohol buzz: an examination of the latent factor structure of subjective intoxication. Alcohol Clin Exp Res. 2009 Dec; 33(12):2154-61. PMID: 19764932.
      View in: PubMed
    134. Ray LA, Oslin DW. Naltrexone for the treatment of alcohol dependence among African Americans: results from the COMBINE Study. Drug Alcohol Depend. 2009 Dec 01; 105(3):256-8. PMID: 19717248.
      View in: PubMed
    135. Magill M, Ray LA. Cognitive-behavioral treatment with adult alcohol and illicit drug users: a meta-analysis of randomized controlled trials. J Stud Alcohol Drugs. 2009 Jul; 70(4):516-27. PMID: 19515291.
      View in: PubMed
    136. Leventhal AM, Waters AJ, Kahler CW, Ray LA, Sussman S. Relations between anhedonia and smoking motivation. Nicotine Tob Res. 2009 Sep; 11(9):1047-54. PMID: 19571250.
      View in: PubMed
    137. Leggio L, Ray LA, Kenna GA, Swift RM. Blood glucose level, alcohol heavy drinking, and alcohol craving during treatment for alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) Study. Alcohol Clin Exp Res. 2009 Sep; 33(9):1539-44. PMID: 19485973.
      View in: PubMed
    138. Ray LA, Hutchison KE. Associations among GABRG1, level of response to alcohol, and drinking behaviors. Alcohol Clin Exp Res. 2009 Aug; 33(8):1382-90. PMID: 19426171.
      View in: PubMed
    139. Ray LA, Miranda R, MacKillop J, McGeary J, Tidey JW, Rohsenow DJ, Gwaltney C, Swift RW, Monti PM. A preliminary pharmacogenetic investigation of adverse events from topiramate in heavy drinkers. Exp Clin Psychopharmacol. 2009 Apr; 17(2):122-9. PMID: 19331489.
      View in: PubMed
    140. Ray LA, Hutchison KE, Leventhal AM, Miranda R, Francione C, Chelminski I, Young D, Zimmerman M. Diagnosing alcohol abuse in alcohol dependent individuals: diagnostic and clinical implications. Addict Behav. 2009 Jun-Jul; 34(6-7):587-92. PMID: 19362427.
      View in: PubMed
    141. Leventhal AM, Kahler CW, Ray LA, Zimmerman M. Refining the depression-nicotine dependence link: patterns of depressive symptoms in psychiatric outpatients with current, past, and no history of nicotine dependence. Addict Behav. 2009 Mar; 34(3):297-303. PMID: 19062199.
      View in: PubMed
    142. Mackillop J, Murphy JG, Tidey JW, Kahler CW, Ray LA, Bickel WK. Latent structure of facets of alcohol reinforcement from a behavioral economic demand curve. Psychopharmacology (Berl). 2009 Mar; 203(1):33-40. PMID: 18925387.
      View in: PubMed
    143. Ray LA, Mackillop J, Leggio L, Morgan M, Hutchison KE. Effects of naltrexone on cortisol levels in heavy drinkers. Pharmacol Biochem Behav. 2009 Feb; 91(4):489-94. PMID: 18824022.
      View in: PubMed
    144. Ray LA, Bryan A, Mackillop J, McGeary J, Hesterberg K, Hutchison KE. The dopamine D Receptor (DRD4) gene exon III polymorphism, problematic alcohol use and novelty seeking: direct and mediated genetic effects. Addict Biol. 2009 Apr; 14(2):238-44. PMID: 18715282.
      View in: PubMed
    145. Filbey FM, Ray L, Smolen A, Claus ED, Audette A, Hutchison KE. Differential neural response to alcohol priming and alcohol taste cues is associated with DRD4 VNTR and OPRM1 genotypes. Alcohol Clin Exp Res. 2008 Jul; 32(7):1113-23. PMID: 18540916.
      View in: PubMed
    146. Ray LA, Hutchison KE, MacKillop J, Miranda R, Audette A, Swift R, Monti PM. Effects of naltrexone during the descending limb of the blood alcohol curve. Am J Addict. 2008 Jul-Aug; 17(4):257-64. PMID: 18612879.
      View in: PubMed
    147. Ray LA, Kahler CW, Young D, Chelminski I, Zimmerman M. The factor structure and severity of DSM-IV alcohol abuse and dependence symptoms in psychiatric outpatients. J Stud Alcohol Drugs. 2008 Jul; 69(4):496-9. PMID: 18612564.
      View in: PubMed
    148. Leventhal AM, Kahler CW, Ray LA, Stone K, Young D, Chelminski I, Zimmerman M. Anhedonia and amotivation in psychiatric outpatients with fully remitted stimulant use disorder. Am J Addict. 2008 May-Jun; 17(3):218-23. PMID: 18463999.
      View in: PubMed
    149. Ray LA, Miranda R, Chelminski I, Young D, Zimmerman M. Diagnostic orphans for alcohol use disorders in a treatment-seeking psychiatric sample. Drug Alcohol Depend. 2008 Jul 01; 96(1-2):187-91. PMID: 18430524.
      View in: PubMed
    150. MacKillop J, Murphy JG, Ray LA, Eisenberg DT, Lisman SA, Lum JK, Wilson DS. Further validation of a cigarette purchase task for assessing the relative reinforcing efficacy of nicotine in college smokers. Exp Clin Psychopharmacol. 2008 Feb; 16(1):57-65. PMID: 18266552.
      View in: PubMed
    151. Miranda R, MacKillop J, Monti PM, Rohsenow DJ, Tidey J, Gwaltney C, Swift R, Ray L, McGeary J. Effects of topiramate on urge to drink and the subjective effects of alcohol: a preliminary laboratory study. Alcohol Clin Exp Res. 2008 Mar; 32(3):489-97. PMID: 18215213.
      View in: PubMed
    152. Miranda R, Rohsenow DJ, Monti PM, Tidey J, Ray L. Effects of repeated days of smoking cue exposure on urge to smoke and physiological reactivity. Addict Behav. 2008 Feb; 33(2):347-53. PMID: 17913381.
      View in: PubMed
    153. Ray LA, Hutchison KE. Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response: a double-blind placebo-controlled study. Arch Gen Psychiatry. 2007 Sep; 64(9):1069-77. PMID: 17768272.
      View in: PubMed
    154. Ray LA, Rhee SH, Stallings MC, Knopik V, Hutchison KE. Examining the heritability of a laboratory-based smoking endophenotype: initial results from an experimental twin study. Twin Res Hum Genet. 2007 Aug; 10(4):546-53. PMID: 17708695.
      View in: PubMed
    155. Ray LA, Miranda R, Kahler CW, Leventhal AM, Monti PM, Swift R, Hutchison KE. Pharmacological effects of naltrexone and intravenous alcohol on craving for cigarettes among light smokers: a pilot study. Psychopharmacology (Berl). 2007 Sep; 193(4):449-56. PMID: 17484067.
      View in: PubMed
    156. Ray LA, MacKillop J, Hutchison KE. Pharmacogenetics of the µ-opioid receptor and the treatment of addictions. Per Med. 2007 May; 4(2):217-220. PMID: 29788631.
      View in: PubMed
    157. Ray LA, Meskew-Stacer S, Hutchison KE. The relationship between prospective self-rating of alcohol sensitivity and craving and experimental results from two alcohol challenge studies. J Stud Alcohol Drugs. 2007 May; 68(3):379-84. PMID: 17446977.
      View in: PubMed
    158. Bryan A, Ray LA, Cooper ML. Alcohol use and protective sexual behaviors among high-risk adolescents. J Stud Alcohol Drugs. 2007 May; 68(3):327-35. PMID: 17446971.
      View in: PubMed
    159. Hutchison KE, Ray L, Sandman E, Rutter MC, Peters A, Davidson D, Swift R. The effect of olanzapine on craving and alcohol consumption. Neuropsychopharmacology. 2006 Jun; 31(6):1310-7. PMID: 16237394.
      View in: PubMed
    160. Ray LA, McGeary J, Marshall E, Hutchison KE. Risk factors for alcohol misuse: examining heart rate reactivity to alcohol, alcohol sensitivity, and personality constructs. Addict Behav. 2006 Nov; 31(11):1959-73. PMID: 16466861.
      View in: PubMed
    161. Hines LM, Ray L, Hutchison K, Tabakoff B. Alcoholism: the dissection for endophenotypes. Dialogues Clin Neurosci. 2005; 7(2):153-63. PMID: 16262210; PMCID: PMC3181729.
    162. Ray LA, Hutchison KE. A polymorphism of the mu-opioid receptor gene (OPRM1) and sensitivity to the effects of alcohol in humans. Alcohol Clin Exp Res. 2004 Dec; 28(12):1789-95. PMID: 15608594.
      View in: PubMed
    163. Fromme K, de Wit H, Hutchison KE, Ray L, Corbin WR, Cook TA, Wall TL, Goldman D. Biological and behavioral markers of alcohol sensitivity. Alcohol Clin Exp Res. 2004 Feb; 28(2):247-56. PMID: 15112932.
      View in: PubMed